3 line items. For ustekinumab syringes/vials. Awarded for a base year of 6/14/2026 to 6/13/2027 plus 4 one-year option periods.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79726D0028
- Awardee
-
Fresenius Kabi, LLC UEI C2TRNWNQKMD6
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Ustekinumab Pens/Syringes or Biosimilar Pre-Solicitation · 36E79726R0006 · Posted Dec 11, 2025
- Last date to order 37% complete
- IDV ceiling
- $139,451,137.40
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 8 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Fresenius Kabi, LLC on June 5, 2026, with a ceiling value of $139.5 million for Ustekinumab syringes and vials. The contract carries a base year running from June 14, 2026 through June 13, 2027, plus four one-year option periods, extending ultimate completion to June 4, 2027. No set-aside was used; the procurement was open to all responsible sources in unrestricted competition.
The solicitation, posted as a pre-solicitation notice on December 11, 2025, sought Ustekinumab pens, syringes, or biosimilar products to supply the VA (including Consolidated Mail Pharmacies and State Veterans Homes), Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. Offerors were required to provide an exact drug name matching the product label with a unique NDC number and were prohibited from affixing their own label over existing labels. The full RFP #36E79726R0006 was issued in commercial item format under FAR Part 12, with a tentative closing date of January 27, 2026. The NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
The contract covers three line items and incorporates Section 5 of Executive Order 14398, Clause 52.222-90, addressing discrimination-free procurement by federal contractors as effective April 2026.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79726D0028?
36E79726D0028 was awarded to Fresenius Kabi, LLC by National Acquisition Center (Headquarters) on June 5, 2026.
How much is contract 36E79726D0028 worth?
36E79726D0028's own ceiling is $139,451,137.
Who can order from contract 36E79726D0028?
36E79726D0028 is a single award indefinite delivery contract.
Was contract 36E79726D0028 competed?
The extent of competition for 36E79726D0028 was full and open competition. The government received 8 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV